NCT07540910 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults Status RECRUITING Phase PHASE1
NCT07408219 A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients Status RECRUITING Phase N/A
NCT07402213 Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. Status NOT_YET_RECRUITING Phase PHASE3
NCT07358780 Remibrutinib in Real-world Clinical Practice - a US Sub-study Status RECRUITING Phase N/A
NCT07316114 A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria Status RECRUITING Phase N/A
NCT07256392 Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Status RECRUITING Phase PHASE3
NCT07230418 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes Status RECRUITING Phase PHASE1
NCT07219615 A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. Status RECRUITING Phase PHASE2
NCT07005713 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06991608 A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06931405 Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) Status RECRUITING Phase PHASE2
NCT06873516 Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06864507 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria. Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06795373 Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria Status WITHDRAWN Phase PHASE2
NCT06604949 A Study of Single Dose of LP-003 in Healthy Adult Subjects Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06577116 Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001 Status COMPLETED Phase PHASE1
NCT06455202 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06445023 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Status ACTIVE_NOT_RECRUITING Phase PHASE3